Postganglionic sympathetic neurons detect vascular derived neurotrophin 3 (NT3) via the axonally expressed receptor tyrosine kinase, TrkA, to promote chemo-attraction along intermediate targets. Once axons arrive to their final target, a structurally related neurotrophic factor, nerve growth factor (NGF), also acts through TrkA to promote final target innervation. Does TrkA signal differently at these different locales? We previously found that Coronin-1 is upregulated in sympathetic neurons upon exposure to NGF, thereby endowing the NGF-TrkA complex with new signaling capabilities (i.e. calcium signaling), which dampens axon growth and branching. Based on the notion that axons do not express functional levels of Coronin-1 prior to final target innervation, we developed an in vitro model for axon growth and branching along intermediate targets using Coro1a −/− neurons grown in NT3. We found that, similar to NGF-TrkA, NT3-TrkA is capable of inducing MAPK and PI3K in the presence or absence of Coronin-1. However, unlike NGF, NT3 does not induce calcium release from intracellular stores. Using a combination of pharmacology, knockout neurons and in vitro functional assays, we suggest that the NT3-TrkA complex uses Ras/MAPK and/or PI3K-AKT signaling to induce axon growth and inhibit axon branching along intermediate targets. However, in the presence of Coronin-1, these signaling pathways lose their ability to impact NT3 dependent axon growth or branching. This is consistent with a role for Coronin-1 as a molecular switch for axon behavior and suggests that Coronin-1 suppresses NT3 dependent axon behavior.
Introduction
During sympathetic nervous system development, nascent axons grow along vascular intermediate targets and then into final target organs (e.g. heart, eye) where they terminate (Baljet and Drukker, 1980; Kummer, 1992; Makita et al., 2008; Pardini et al., 1989) . Growth of sympathetic axons along vascular intermediate targets is mediated by neurotrophin-3 (NT3) and final target innervation is mediated by a paralog, nerve growth factor (NGF) Francis et al., 1999; Harrington and Ginty, 2013; Kuruvilla et al., 2004) . Both NT3 and NGF signal through the receptor tyrosine kinase (RTK), TrkA (Belliveau et al., 1997; Kuruvilla et al., 2004) .
Neurotrophin-dependent signaling is at least as dynamic as the axonal behaviors it mediates. Axons growing along blood vessels likely experience signaling that suppresses branching while allowing growth (Carmeliet, 2003) . Once axons reach their final target, these NT3 dependent axon behaviors must become muted, in order to accommodate growth properties consistent with rapid arborization within the final target (Shirasaki et al., 1998) . In order to achieve this diversity of axon growth behaviors, we suggest that neurotrophin (NT3 versus NGF) signaling must be differentially interpreted at each stage of target innervation, especially between intermediate and final targets.
Upon sympathetic final target innervation, one of the most robustly up-regulated genes is Coronin-1 (Deppmann et al., 2008; Suo et al., 2014) . Prior to NGF dependent Coronin-1 upregulation, we previously found that NGF-TrkA-PI3K signaling promotes robust axon growth and branching as axons first enter their final targets. Upon Coronin-1 upregulation, NGF-TrkA-calcium signaling dampens axon growth and branching, which is a behavior consistent with axons finding termination zones. In the absence of Coro1a, sympathetic neurons display excessive branching and overshoot their final targets (Suo et al., 2015) . How NT3-TrkA signaling is different from these scenarios as axons grow along vasculature toward their final targets remains an open question. A comparison of the signaling pathways that NGF and NT3 can initiate via TrkA may shed light on this.
The finding that final target innervation (NGF exposure) is required for Coronin-1 expression in developing sympathetic neurons also implies that Coronin-1 is not expressed as sympathetic axons move along their intermediate targets (NT3 exposure) (Suo et al., 2015) . Indeed, immunohistochemistry in the developing superior cervical ganglia (SCG) reveals undetectable Coronin-1 protein expression until times after axons have reached their final target at roughly E16.5 (Coronin-1 expression is present at E18.5 and peaks at P0) Manousiouthakis et al., 2014; Suo et al., 2014) . While it is possible to dissect sympathetic neurons prior to final target innervation, establishing these sympathetic neurons in microfluidic devices in the absence of NGF results in neuron death. Interpretation of NT3 signaling must account for the upregulation of Coronin-1 upon NGF exposure (Suo et al., 2014 (Suo et al., 2015) . We further characterized the signaling pathways underlying these behaviors. Unlike NGF, NT3 is unable to evoke a calcium release regardless of Coronin-1 expression. Similar to NGF-TrkA, NT3-TrkA is capable of inducing MAPK and PI3K, however these pathways appear to be used in a different manner in the context of growth and branching. For instance, NT3-TrkA requires the MAPK pathway to promote axon growth and suppress axon branching, but only in the absence of Coronin-1; whereas MAPK signaling was dispensable for NGF-TrkA axon behaviors (Suo et al., 2015) . In the absence of Coronin-1, NGF dependent PI3K signaling promotes exuberant axon branching and growth whereas NT3 dependent PI3K activity suppresses branching while retaining the ability to promote growth (Suo et al., 2015) . These data support a model whereby NT3 drives axon growth and branch suppression in a MAPK/PI3K-dependent manner. However, when Coronin-1 is present NT3 dependent MAPK/PI3K no longer effects axon growth. These findings re-enforce the notion that Coronin-1 represents a molecular switch that allows differential interpretation of neurotrophin signaling capable of driving 3 distinct profiles of axon growth behavior.
Materials and methods

Reagents
Antibodies were previously validated for the applications used. The dilutions and applications were as follows: Coronin-1a (Abcam, ab53395, 1:400 for immunohistochemistry); Tubb3 (Covance, MMS-435P-250, 1:400 for immunohistochemistry); rhodamine phalloidin (Life Technologies, R-415 1:400 for immunohistochemistry); phospho-p44/42 MAPK (Erk1/2) mouse mAb (cell signaling, #9106, 1:1000 for Western blot); pan-p44/42 MAPK(Erk1/2) antibody (cell signaling, #9102s, 1:1000 for Western blot); anti-tyrosine hydroxylase (Millipore, AB1542 1:130 for immunohistochemistry); horseradish peroxidase-conjugated donkey anti-sheep IgG (Fisher/Jackson Immuno Research, NC9754415 1:250); 3,3′-diaminobenzidine tetrahydrochloride tablet (Sigma, D5905-50TAB, 1 tablet: 20 ml for staining); neurotrophin 3 (Millipore, GF031); U-73122 (Sigma, U6756); GSK3β inhibitor XIX (Millipore, 361565); ionomycin (Sigma, I9657); BAPTA-AM (Invitrogen, B-1205); LY294002 (Sigma, L9908); BEZ235 (Selleckchem, S1009); PD0325901 (Selleckchem, S1036).
Animals
All animal protocols followed are as described previously (Suo et al., 2014) and were conducted in accordance with Association for Assessment of Laboratory Animal Care Policies and approved by the University of Virginia Animal Care and Use Committee. Sprague Dawley rats were purchased from Harlan. Sympathetic neurons were dissected from P0-P2 rats or mice of either sex as previously described {Zareen, 2009 #39} (Zareen and Greene, 2009 ). All mice were in a C57BL/6 background and J. Pieters generously provided the Coro1a −/− mice.
Genotyping was performed as described previously (Jayachandran et al., 2007) .
Tissue culture
Sympathetic neuron cultures were plated as previously described (Deppmann et al., 2008) . Mass culture and microfluidic culture media was Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum (FBS), penicillin-streptomycin (1 U ml −1 ), 45 ng/ml of mouse salivary glands purified NGF. Aphidicolin was applied for 48 h after plating to remove glia contamination.
Immunocytochemistry
Immunocytochemistry and immunohistochemistry was performed as previously described (Sharma et al., 2010) . At room temperature samples were fixed by 4% paraformaldehyde and blocked for 30 min using 5% goat serum and 0.05% Triton X-100 in PBS. Next, primary antibody was applied overnight at 4°C. Secondary antibody was applied for 1 h at room temperature. Samples were washed three times using 1× PBS and mounted in Vectashield fluoromount. Images were collected using confocal microscopy.
Immunoblot analysis
Immunoblot analysis was performed as previous described (Mandai et al., 2009) . Briefly, sympathetic neurons were harvested by boiling in 2× Laemmli buffer for 10 min. SDS-PAGE followed by western blot analysis was performed using the indicated antibodies and LI-COR for visualization.
Microfluidic devices
Microfluidic devices were generated and used as previous description (Park et al., 2006) . Chambers were attached to glass cover slips coated with poly-D-lysine (50 μg/ml) and laminin (1 μg/ml). A 100 μl volume difference was maintained between two compartments to ensure fluidic isolation.
Axon growth assay
P0-P3 sympathetic superior cervical ganglia neurons were plated in the cell body chamber of a microfluidic device in the presence of NGF and aphidicolin (5 μM). After 2-3 days axons emerged in the distal axon chamber of the microfluidic device at which time NGF was deprived for 17 h by adding anti-NGF and Bocaspartyl(OMe)-fluoromethylketone (BAF; 5 μM). The axon chamber media was then changed to anti-NGF (1 μg/ml) or NT3 (100 ng/ml) and images of the entire distal axon chamber field were acquired at this 'zero time point'. After 24 h, images of the same axon were reacquired and axon growth rates were quantified as the difference between the two datasets.
Growth cone staining
Staining protocol was adapted from previous studies by Letourneau and colleagues (Marsick and Letourneau, 2011) . Coverslips were coated with laminin (40 μg/ml) for 2 h before plating. P0-P3 sympathetic neurons were established in mass culture as described above and were then treated with either anti-NGF (1 μg/ml) with BAF (5 μM) or NT3 (100 ng/ml) for 24 h. Neurons were fixed with 4% PFA containing Ca 2 + (1.5 mM) and Mg 2 +
(1 mM). Double immunostaining was then performed with Tuj1 and Phalloidin. Images were acquired using 63 × confocal microscopy.
Branch assay
P0-P3 sympathetic neurons were plated in mass culture with anti-NGF or other treatment as indicated. After 1 day in culture neurons were fixed with 4% PFA. Double immunostaining was then performed with Tuj1. Images were taken using 10× confocal microscopy and analyzed by Sholl analysis as previously described (Suo et al., 2015) . The area under the curve of each Sholl analysis curve was determined in Prism 7 and compared.
Results
Establishing Coro1a
−/− neurons as a model for axon behavior along intermediate targets
We first sought to explore the role of Coronin-1 in NT-3 dependent axon growth of sympathetic neurons in vitro. We established sympathetic neurons from Coro1a −/− or WT (Coro1a
) mice in microfluidic devices to separate axons from cell bodies and provide easily identifiable landmarks to find the same axon from day to day (Fig. 1A) (Park et al., 2006) . All neurons were established in 45 ng/ml NGF until axons traversed the microgrooves. NGF was then washed out and 100 ng/ml NT3 or 1 μg/ml anti-NGF were added exclusively to distal axons under fluidic isolation, while the cell bodies and proximal axons were treated with anti-NGF and a broad spectrum caspase inhibitor, bocaspartyl(OMe)-fluoromethylketone (BAF), to prevent apoptosis. Positive and negative growth of individual axons was measured over a 24-hour period. The presence of Coronin-1 had no effect on NT3-dependent axon growth rate (Fig. 1B) . This is in contrast to what is observed for NGF treated axons from wild type and Coro1a −/− neurons, which grow at approximately 75 and 150 μm/day, respectively (Suo et al., 2015) . Coronin-1 is also required for the ability of NGF to produce large growth cones, which are associated with slower axon growth rate and greater turning/branching capacity (Argiro et al., 1984; Bray and Chapman, 1985; Suo et al., 2015) . Therefore, we next examined growth cone area in NT3 treated neurons from Coro1a −/− and WT mice. Remarkably, we observed that growth cones of NT3-treated WT neurons were small and compact consistent with previous findings (Kuruvilla et al., 2004 ) whereas NT3-treated Coro1a −/− neurons displayed large bulbous tips (Fig. 1C, D) . This is in contrast to our previous observation that NGF treated growth cones are small in the absence of Coroinin-1 (Suo et al., 2015) . We next examined the role of Coronin-1 in NT3-dependent axon branching. Sympathetic neurons from P0 Coro1a −/− or WT mice were sparsely cultured for 1 day in vitro (DIV) in the presence of NT3. Neurons were immunostained for β3-tubulin and branching was assessed via Sholl analysis as previously described (Magarinos et al., 2006; Suo et al., 2015) . We found that NT3-induced branching was depressed in the absence of Coronin-1 compared to in WT neurons (Fig. 1E, F) . Fig. 2 . Coronin-1 alters NGF-and NT3-induced calcium release but has no effect on P-Erk or P-Akt signaling. (A) NT3 dependent P-ERK3β, P-AKT, or P-GSK3β induction in sympathetic neurons cultured from wild-type or Coro1a −/− mice for 2-3 DIV. Neurons were deprived of NGF for 17 h then treated with anti-NGF or NT3 for 20 min followed by immunoblot analysis for P-ERK, ERK, P-AKT, AKT, P-GSK3β, and GSK3β. (B-D) Quantification of the data in A. Experiments were quantified with densitometry and P-Erk and P-AKT signals were normalized to total ERK and AKT, respectively (n = 3). (E) NT3 is unable to induce calcium release in a Coronin-1 dependent manner. Sympathetic neurons isolated from wild-type or Taken together, the axon behaviors that we observe in NT3 treated neurons from Coro1a −/− mice are consistent with growth along intermediate targets; steady axon growth, large growth cones for pathfinding, and minimal branching to maintain fascicles. The presence of
Coronin-1 reveals a unique NT3 dependent axon growth profile with collapsed growth cones and increase branching, which would be consistent with axons transitioning into final target organs. However this condition likely plays a limited physiological role since neurons that express Coronin-1 are also exposed to NGF, which preferentially binds to TrkA over NT3. Herein, we model growth along the intermediate targets using NT3 treated axons from Coro1a −/− mice.
Coronin-1 is dispensable for NT3-TrkA induced signaling
We have previously found that Coronin-1 influences several NGFTrkA dependent pathways relevant to axon growth properties including GSK3β phosphorylation and calcium release (Suo et al., 2015) . We next sought to determine whether this is also true for NT3-TrkA signaling. We began by examining whether Coronin-1 influences NT3-TrkA-dependent ERK, PI3K, and GSK3β activation. To this end we cultured sympathetic neurons from Coro1a −/− and WT mice in order to assess NT3
(100 ng/ml) dependent p-ERK, p-AKT, and GSK3β levels ( Fig. 2A) . Importantly, NT3 induced similar levels of p-ERK, p-AKT, and p-GSK3β in both Coro1a −/− and WT neurons, suggesting that Coro1a −/− is not necessary for NT3-TrkA activation of these pathways ( Fig. 2A-D) . The dispensability of Coronin-1 for NT3-TrkA induced p-AKT and p-ERK is similar to what is observed in NGF-TrkA activation of these pathways (Suo et al., 2015) . However, NT3-TrkA is capable, while NGF-TrkA is not capable, of inducing an inactivating phosphorylation event on GSK3β in the presence of Coronin-1. Inactivation of GSK3β has been associated with increased axon growth rate and branching (Suo et al., 2015; Zhou et al., 2004) . We have previously found that Coronin-1 is required for NGF dependent calcium release from intracellular stores (Suo et al., 2014) . Therefore, we next sought to determine whether NT3 influences calcium release in the presence or absence of Coronin-1. To this end we loaded cells with the calcium indicator, Fluo-4, for 20 min followed by treatment with increasing concentrations of NT3 for 15 min. In contrast to NGF (Suo et al., 2014) , NT3 failed to promote calcium release in both WT and Coro1a −/− neurons (Fig. 2E, F) . Taken together, these data suggest that NT3 dependent processes like axon growth may involve activation of Ras-MAPK and PI3K-AKT pathways as well as inhibition of GSK3β. However, calcium signaling is likely not used to mediate NT3-TrkA dependent processes.
3.3. NT3-TrkA-dependent MAPK/MEK signaling is required to promote axon growth and suppress branching in the absence of Coronin-1
We next sought to determine whether MAPK signaling downstream of NT3-TrkA is required in our model for axon growth and branching along intermediate targets using neurons from Coro1a −/− mice. We first performed axon growth assays as described in Fig. 1 , on NT3 treated neurons from Coro1a −/− or WT mice in the presence or absence of the MEK inhibitors, PD98059 or PD0325901. In Coro1a −/− neurons treated with NT3, both PD98059 and PD0325901 reduced the rate of NT3-dependent axon extension by 40% (Fig. 3A) . However, in WT neurons neither PD98059 nor PD0325901 had an effect on NT3 dependent axon growth. We next examined the role of MEK in NT3-dependent branching. Interestingly, both PD98059 and PD0325901 enhanced branching of NT3 treated Coro1a −/− neurons, with no effect on WT neurons ( Fig. 3B-E) . Taken together, these data suggest that the presence of Coronin-1 masks a role for RAS-MAPK signaling in NT3 dependent axon growth and branching. In this model of axon growth along intermediate
), NT3-TrkA signaling to RAS/MAPK promotes axon growth and inhibits branching (Fig. 3F) . 3.4. NT3-TrkA-dependent PI3K signaling is required to promote axon growth and suppress branching in absence of Coronin-1
We next examined the role of PI3K signaling in regulating axon behaviors in the absence and presence of Coronin-1. The PI3K inhibitor, LY29002, inhibited axon growth of NT3-treated neurons from Coro1a −/− mice but exhibited no effect on the growth of WT neurons (Fig. 4A) . Additionally, LY29002 enhanced branching of neurons from Coro1a −/− mice grown in NT3, but had no effect on WT neurons grown in NT3 (Fig. 4B-E ). Taken together with MEK inhibitor experiments (Fig. 3) , these data suggest that both NT3-TrkA-MAPK and NT3-TrkA-PI3K signaling suppresses branching along intermediate targets and are required for NT3-dependent axon growth in this niche where Coronin-1 levels are below the level of detection (Fig. 4F) .
Calcium signaling is dispensable for NT3-TrkA dependent axon growth
In neurons from both Coro1a −/− and WT mice, we observe an inability of NT3 to induce calcium release. However, it is formally possible calcium signaling is still required for axon growth and branching. The calcium chelator, BAPTA-AM (1 μM), had no effect on growth in NT3-treated Coro1a −/− neurons, but suppresses axon growth of NT3-treated WT neurons (Fig. 5A ). This is in contrast to our previous observation that BAPTA-AM doubles the axon growth rate of NGF treated WT neurons (Suo et al., 2015) . BAPTA-AM had no effect on NT3-dependent branching in neurons from Coro1a −/− or WT mice ( Fig. 5B-E ). Taken together with our finding that NT3 is unable to induce calcium release (Fig. 2D, E) , these data suggest that calcium signaling plays little role in NT3 dependent growth and branching (Fig. 5F ).
NT3-TrkA-dependent GSK-3β inhibition is required for axon growth
We previously showed that NGF-TrkA-Coronin-1 suppressed axon growth and branching downstream of PI3K signaling by disinhibiting GSK3β (Suo et al., 2015) . Thus, we sought to discern whether GSK3β inhibition (analogous to the phosphorylated state) influences NT3 dependent axon growth and branching. We assessed the axon growth of NT3-treated neurons from Coro1a −/− or WT mice with or without GSK3β inhibitor XIX (200 nm:GSKi). Both Coro1a −/− and WT neurons displayed a decrease in NT3 dependent axon growth when GSK3β was inhibited (Fig. 6A) . However, GSKi caused no change in the already depressed NT3 dependent branching in Coro1a −/− or WT neurons (Fig. 6B-E) .
These data contrast previous work, which suggests that inhibition of GSK3β via phosphorylation is required for NGF dependent axon growth (Suo et al., 2015; Zhou et al., 2004) . Here we find the opposite. Inhibition of GSK3β presumably via phosphorylation suppresses NT3 dependent axon growth. Moreover, the fact that GSK3β inhibition does not further depress branching underscores the notion that unlike NGF, NT3 does not engage a pro-branching signaling program (Fig. 6F ).
Discussion
Here, we have examined the signaling underlying NT3-TrkA dependent axon growth. We and others have previously identified genes that are upregulated in sympathetic neurons upon final target innervation (i.e. Coronin-1, TrkA, and p75NTR) (Deppmann et al., 2008; Kuruvilla et al., 2004; Suo et al., 2014) . This previous work reveals a flaw in current in vitro models of growth along intermediate targets. Because sympathetic neurons are typically dissected from mice after they have encountered NGF in vivo (p0-p3) and are then established in vitro in NGF, they express many final target dependent genes. Our previous finding that Coronin-1 is a critical molecular switch between final target axon transition and termination niches allowed us to develop an in vitro model system that more accurately reflects the molecular state of sympathetic axons growing along intermediate targets (neurons from Coro1a −/− mice grown in NT3). With this model system, we uncover key differences between NT3-TrkA and NGF-TrkA dependent signaling and axon growth. These differences reveal at least 3 distinct niches of axon growth: along intermediate targets, entering the final target prior to Coronin-1 upregulation, and terminating in final targets after Coronin-1 upregulation (Fig. 7) . As sympathetic axons grow along the intermediate target, NT3-TrkA activates MAPK as well as PI3K and inhibits GSK3β (Fig. 2) . Inhibition of GSK3β likely occurs downstream of PI3K as has been previously reported (Saijilafu et al., 2013) . In this intermediate target niche, both MAPK and PI3K are critical for promoting axon growth and inhibiting branch formation, which is consistent with the idea that while it is important for fascicles to pathfind along blood vessels, they should not arborize (Figs. 3, 4) . Intriguingly, the presence of Coronin-1 appears to uncouple MAPK and PI3K from NT3-TrkA dependent axon growth and branching behaviors. We suggest that upon exposure to NGF and upregulation of Coronin-1, NT3-TrkA signaling is masked with respect to promoting growth and branching. This could be via an unknown Coronin-1 dependent mechanism or a coincident Coronin-1 independent event. For example, the up regulation of p75NTR expression that accompanies final target innervation depresses the ability of NT3 to signal through TrkA (Kuruvilla et al., 2004) . Unlike MAPK and PI3K pathways, the inhibition of GSK3β via phosphorylation depresses axon growth but has no effect on branching (Fig. 5) . This signaling is consistent with previous work showing drastic reduction in the axon growth of DRG neurons exposed to GSK3β inhibitors (Kim et al., 2006) . NGF emanating from final target organs has a roughly 10 fold greater affinity for TrkA than NT3 (Belliveau et al., 1997) . As these axons Comparison of pathways involved in axon growth and branching examined here and in Suo et al. (2015) .
transition from the intermediate target to the final target, NGF outcompetes NT3 for TrkA binding. In this transition zone niche, NGF-TrkA activates the same pathways as NT3-TrkA, however, axon growth and branching no longer rely on RAS-MAPK signaling (Suo et al., 2015) . PI3K appears to be the principal TrkA dependent pathway used to drive axon growth in this niche, which manifests as robust axon growth and branching to rapidly arborize the final target (Suo et al., 2015) .
Modulation of calcium levels within growing axons is inextricably tied to axonal behavior (Mattson and Kater, 1987; Song et al., 1997) . Rapidly growing axons with minimal turning or branching exhibit lower levels of calcium while slower axonal growth correlates with higher levels of calcium (Robles et al., 2003; Song et al., 1997) . As sympathetic axons are exposed to a threshold concentration of NGF for a threshold period of time, Coronin-1 is upregulated, which endows the NGF-TrkA complex with the ability to induce calcium release, in concert with PLC-gamma signaling (Suo et al., 2014) . This calcium signaling inhibits pathways downstream of PI3K in order to disinhibit GSK3β leading to a suppression of NGF dependent axon growth and branching (Suo et al., 2015) . In the absence of Coronin-1, axons over-branch and overshoot their final target fields, in vivo. While NGF signaling results in robust calcium release as part of its control over axonal growth and branching (Suo et al., 2014; Suo et al., 2015) , we found that NT3 does not cause calcium release regardless of whether or not Coronin-1 is present (Fig. 2D, E) . Consistent with this, blocking calcium signaling in the absence of Coronin-1 has no effect on NT3-TrkA dependent axon growth or branching (Fig. 5) .
How can NT3 and NGF signaling through the same receptor result in such dramatically different axon growth properties? It has been reported that while NGF-TrkA can internalize into persistent signaling endosomes capable of trafficking long distances, NT3-TrkA cannot (Kuruvilla et al., 2004) . Although, NT3-TrkA is capable of internalizing, the complex recycles back to the surface rapidly and does not traffic long-distances (Harrington et al., 2011) . This is because NT3-TrkA dissociates in the acidic lumen of the endosome, whereas NGF-TrkA is stable under these conditions (Harrington et al., 2011) . This transient versus persistent internalization of TrkA is likely the critical determinant for differences in axon growth and branching properties across the 3 niches that we describe (Fig. 7) . Indeed, it is known that the TrkA signaling endosome adds effector proteins (e.g. rac1, Erk5, Cofilin, Coronin-1) as a function of trafficking and maturation (Barford et al., 2016; Harrington et al., 2011; Suo et al., 2014; Watson et al., 2001) . It is likely that these effector proteins endow NGF-TrkA with the ability to induce axon growth properties distinct from NT3-TrkA.
Future work will be needed to discern whether other Type I Coronin family members also act as molecular switches in these neurons. Additionally, it will be important to determine whether this is specific to sympathetic neurons or a more general principle of neurons as they grow toward their final target. We expect that while the molecular players may not be identical across neuron types, the phases of growth that we describe here and previously will be broadly applicable.
